Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN brand material UTHEVER®

      2020 Nutrition Health Entrepreneur Conference (NHEC) was hosted in Bejing International Conference center on Nov.22nd, 2020.
      With the theme of “Embracing the Future of change and Win-win,” this annual conference brings together leaders from national ministries and commissions, authoritative experts in the nutrition and health industry, and top entrepreneurs from the global-wide health industry. It provides “decision-making” and “connection” support for developing China’s future nutrition industry through forward-looking and systematic industrial information exchange.

      NHEC

      Since professor David Sinclair and other international scientists confirmed that NMN is available to make 22 months mice body back to 6 months (the equivalent of human from 60 to 20 years younger), NMN has aroused attention from Different industries. And the triggered marketing potential makes the quality of NMN raw material uneven.

      And in this context, Effepharm stands out and use the standard of pharmaceutical R&D and USP guidance to provide more reliable, more affordable, healthy ingredients for worldwide clients. Uthever® is also the only NMN manufacture which conducted clinical trials so far.

      The brand NMN raw material UTHEVER® launched by Effepharm has successfully improved the original NMN extraction process and significantly improved the quality of NMN material’s density and stability.

      NHEC

      Therefore, among the many declared products, UTHEVER® stood out and won the top 10 hot raw materials in the nutrition and health industry after the comprehensive evaluation of the project potential, project frontier, scientific and technological content, etc.

      NHEC

      Hank Hwang, the pharmaceutical regulatory director and former USP scientist of Effepharm, said the reward represents that the industry has recognized Effpharm’s exploration and efforts in the field of NMN. Effepharm has long cooperated with top universities and research institutes and carried out more projects on NMN’s application in medicine, such as cancer adjuvant drugs and other disease treatment projects.
      Simultaneously, with the help of IDS®, the company’s self-developed ingredient delivery system platform, Effepharm is also at the forefront of other dietary supplement research.

      Hank also said that the overall development of the health industry is a process of cooperation and cooperation. In the future, Effepharm will keep cooperating with more companies in the industry about the development and production of products with more market potential that people need to contribute to the development of the whole business.

  • Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN Brand Material UTHEVER®

    Asiaceutical Summit & Expo 2020 took place in Guangzhou from October 21st to 23rd. This conference was hosted by the Herbridge, which gathered the experts in foods, beverage and health care industry. Experts provided cutting edge perspectives under the circumstances of...
  • Meet us at Asiaceutical Summit & Expo 2020

    From 21Oct to 23Oct 2020, Effepharm will attend Asiaceutical Summit & Expo 2020 in Guangdong, China. As an exhibitor, our booth will be B17. At the expo, Effepharm will introduce its next-generation NMN - Uthever® to our customers and the...
  • Clinical evidence on the safety of NMN released recently

    Researchers from Keio University and Washington University published a new article on Endocrine Journal. The safety of single dose at 100, 250, and 500 mg NMN was investigated in 10 Japanese men. Clinical findings and parameters, and the pharmacokinetics of NMN metabolites were...
  • Effepharm started new clinical trials on Uthever™ as

    Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to ICTRP ( International Clinical Trials Registry Platform),  the clinical trial on UtheverTM is the largest scale trial on NMN in the world. What’s more, Effepham is the first and the...
  • Effepharm announced acquisitions and new R&D center establishment

    Effepharm acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has significantly enhanced our R&D capability in anti-aging and energy metabolism. Also Effepharm’s new R&D center is established. Effepharm’s new R&D center will focus on new pharmaceutical...
  • Effepharm team at ”Hi Japan”

      From 2nd to 4th Oct 2019, Effepharm team participated in Hi Japan Exhibit, the Largest Trade Show for Functional & Health Ingredients in Japan. Effepharm is in line with the purpose of this event. Its Highlights: not only the food...
  • Effepharm team in the Vitafoods Europe 2019

    On 7th May, 2019, Sales team at Effepharm came to vitafoods with latest products and new technology. Booth Position:Sliver Area  No. N189 NMN- Popular NAD+ Precursors CBD- This ingredient is very popular in many Europe countries. Effepharm’s R&D has scheduled...
  • New Laboratory has been completed!

    Effepharm Ltd. currently not only holds a strong R&D team consisting of experienced  PHDs and Postdocs returned from abroad, but also employs senior professors and  scholars at home and abroad as a team of research consultants to help us optimize ...
  • Meet Us at the Vitafoods Europe 2019!

      May. 2019, Effepharm teams will participate in Vitafoods Europe 2019 Exhibit, a annual event where the global  nutraceutical supply chain come to gether to do business At that time, Effepharm teams will be waiting for your inquiry and cooperation...
  • “Once-in-two-lifetimes Ingredients”–NMN or NR?

    “Once-in-two-lifetimes Ingredients”--NMN or NR? Nowadays, the people all over the world spend billions of dollars on anti-aging products. While most anti-aging products try to reverse signs of aging on your skin, Nicotinamide Rboside aims to reverse signs of aging from inside your...
  • Sales Office transferred to Shanghai

    Sales Office transferred to Shanghai The sales office was transferred to Shanghai in 2017-EffePharm(Shanghai)Co.,Ltd At Effepharm, we apply science and technologies to improve health and well-being at every stage of life with innovative thinking. Our dedicated team strive to set...